시료 준비 시장 규모, 점유율, 동향 및 예측 : 제품별, 용도별, 최종사용자별, 지역별(2026-2034년)

The global sample preparation market size was valued at USD 9.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 14.16 Billion by 2034, exhibiting a CAGR of 5.05% from 2026-2034. North America currently dominates the market, holding a market share of 30% in 2025. The region benefits from its robust pharmaceutical and biotechnology research and development (R&D) infrastructure, widespread adoption of advanced genomics and proteomics-driven workflows, the growing prevalence of chronic diseases requiring precise molecular diagnostics, and the strong concentration of leading life sciences enterprises and research institutions expanding the sample preparation market share.

The global sample preparation market is experiencing sustained growth driven by multiple converging forces. The increasing adoption of advanced analytical techniques, including mass spectrometry, chromatography, and next-generation sequencing across pharmaceutical, biotechnology, and clinical laboratories, is creating consistent demand for efficient upstream sample processing solutions. The rising global prevalence of chronic diseases, including cancer, diabetes, and cardiovascular disorders, is intensifying the demand for molecular diagnostics, underscoring the critical role of sample preparation. Furthermore, advancements in automation technologies are streamlining laboratory workflows, reducing human error, and enhancing throughput across research and diagnostic facilities. The surge in personalized medicine initiatives and genomics research is also supporting the sample preparation market growth across diverse healthcare, pharmaceutical, and academic research verticals worldwide.

The United States has emerged as a major region in the Sample Preparation market owing to many factors. The country's highly developed life sciences ecosystem, encompassing a dense network of pharmaceutical companies, biotechnology firms, and academic research centers, creates a consistent and growing demand for reliable sample preparation solutions. Significant investment in precision medicine and genomics-driven research programs has accelerated the adoption of advanced sample preparation instruments and kits across clinical and research settings. Regulatory standards enforced by federal agencies mandate rigorous analytical procedures, reinforcing the use of standardized sample preparation methodologies in drug development, food safety testing, and environmental monitoring. According to the National Cancer Institute (NCI), approximately 2 million new cancer diagnoses are expected in the United States in 2025, sustaining demand for molecular diagnostics and genomic profiling workflows that depend on effective sample preparation. The sample preparation market outlook in the United States remains highly positive as laboratory automation adoption continues to accelerate across both commercial and academic research environments.

SAMPLE PREPARATION MARKET TRENDS:

Expanding Automation in Laboratory Workflows

The global sample preparation market is significantly shaped by the rapid integration of automation into laboratory workflows. As pharmaceutical, biotechnology, and clinical laboratories scale their operations to meet growing diagnostic and research demands, manual sample processing is increasingly being replaced by automated systems that deliver enhanced throughput, reproducibility, and consistency. Automated platforms reduce the risk of cross-contamination, minimize operator-dependent variability, and enable simultaneous processing of multiple samples, making them indispensable in high-volume laboratory settings. The development of intelligent liquid handling systems, extraction workstations, and modular automation platforms has greatly expanded the capabilities available to laboratory operators. These systems are increasingly integrated with digital connectivity solutions, enabling remote monitoring, software updates, and data tracking across distributed laboratory networks. The growing adoption of artificial intelligence within automated instruments is enabling self-optimizing protocols that adapt to sample matrix variability. In April 2025, QIAGEN announced the phased launch of its next-generation QIAsymphony Connect automated sample preparation system, capable of processing up to 96 samples simultaneously with enhanced digital connectivity and improved automation capabilities for oncology, genomics, and clinical research workflows, reinforcing the trajectory of automation-led growth in the sector.

Pharmaceutical and Biotechnology Sector Expansion

The pharmaceutical and biotechnology sectors are among the primary drivers shaping the sample preparation market trends globally. As novel drug discovery, biologics development, and personalized medicine initiatives proliferate, the demand for accurate, reliable, and standardized sample preparation has intensified considerably. The need to isolate, purify, and concentrate proteins, nucleic acids, and metabolites for downstream analyses is fundamental to the drug development process, ensuring data integrity and reproducibility across all research stages. Genomic and proteomic profiling, which form the backbone of modern biopharmaceutical research, require meticulous upstream processing to maintain sample quality and minimize analytical interference. Stringent regulatory frameworks governing drug development necessitate validated sample preparation protocols that ensure compliance with data integrity standards. The increasing focus on liquid biopsy and cell-free DNA extraction is opening new frontiers for non-invasive diagnostics that demand precision-grade sample processing. According to the World Health Organization, non-communicable diseases account for approximately 74% of all deaths globally, elevating the international urgency for advanced molecular diagnostics and the sample preparation technologies that support their development.

Rising Environmental and Food Safety Testing Demands

The expanding scope of environmental monitoring and food safety testing is a critical driver of the global sample preparation market forecast. As regulatory agencies worldwide tighten permissible limits for contaminants, pesticides, heavy metals, and foodborne pathogens, the requirement for highly sensitive and reliable analytical methods has escalated substantially. Environmental samples such as water, soil, and air particulates involve complex matrices that necessitate thorough extraction, cleanup, and concentration before instrument-based analysis. Similarly, the detection of allergens, additives, and adulteration markers in food products demands meticulous sample preparation to achieve the sensitivity required for regulatory compliance. Advances in solid-phase extraction, dispersive solid-phase extraction, and QuEChERS methodologies have expanded the analytical toolkit available to professionals in environmental and food safety disciplines. The growing demand for miniaturized and high-throughput sample preparation formats is enabling faster turnaround times and lower solvent consumption, supporting both cost efficiency and sustainability goals. In 2025, New England Biolabs (NEB(R)) has announced the introduction of the NEBNext Low-bias Small RNA Library Prep Kit, aimed at reducing biased representation of small RNA types in sequencing results. This next generation method for preparing small RNA is quicker, less biased, and accommodates a wider input range compared to other kits available for purchase.

SAMPLE PREPARATION INDUSTRY SEGMENTATION:

Analysis by Product:

• Sample Preparation Instruments
  • Extraction System
  • Workstation
  • Automated Evaporation System
  • Liquid Handling Instrument
  • Others
• Consumables
• Sample Preparation Kit
  • Purification Kit
  • Isolation Kit
  • Extraction Kit

Sample preparation Instruments holds 40% of the market share. Sample preparation instruments comprise the specialized equipment used to process, extract, purify, and transform biological and chemical specimens into analytically suitable formats across diverse laboratory applications. These instruments include extraction systems, liquid handling platforms, automated workstations, and evaporation units, each engineered to address specific stages of the sample processing workflow with precision and efficiency. The dominance of this segment is driven by the widespread integration of automation in laboratory environments, where instrument-based systems replace manual, time-intensive protocols, delivering enhanced throughput, consistency, and reproducibility. Pharmaceutical and biotechnology laboratories rely extensively on these instruments for nucleic acid extraction, protein isolation, and metabolite profiling fundamental to drug discovery and clinical research pipelines. The growing adoption of digitally connected and modular instrument platforms capable of interfacing with laboratory information management systems is further expanding their utility.

Analysis by Application:

• Proteomics
• Genomics
• Epigenomics

Genomics leads the market with a share of 36%. Genomics represents the study, analysis, and sequencing of complete genetic material to understand structure, function, and evolution across organisms. As a primary application for sample preparation technologies, genomics encompasses DNA extraction, RNA isolation, library preparation for next-generation sequencing, and nucleic acid purification, all of which demand high-quality upstream specimen processing. The widespread adoption of genomics in drug discovery, disease diagnosis, agricultural biotechnology, and personalized medicine continues to propel demand for specialized sample preparation kits and instruments. Standardized and validated sample preparation protocols are essential to maintaining nucleic acid integrity and reproducibility in genomic analyses, directly influencing the reliability of downstream sequencing results. The integration of genomics into routine clinical diagnostics, including liquid biopsy and hereditary disease screening, is further expanding application scope. The expanding sample preparation market forecast reflects the increasing centrality of genomics across healthcare and research sectors globally.

Analysis by End User:

• Pharmaceutical or Biotechnology Companies
• Food and Beverages Industry
• Research and Academic Institutes

Pharmaceutical or biotechnology companies dominates the market, with a share of 35%. Pharmaceutical and biotechnology companies represent the leading end-user segment in the sample preparation market, driven by their extensive reliance on robust, standardized sample processing workflows across every stage of the drug development lifecycle. From early-stage target identification and lead optimization to preclinical testing and clinical validation, these organizations require precise sample preparation to ensure the accuracy, reproducibility, and regulatory compliance of analytical data. The extraction and purification of proteins, nucleic acids, lipids, and small molecules are routine activities within pharmaceutical and biotechnology laboratories, where sample quality directly impacts the validity of research outcomes. Increasing investments in biologics development, gene therapies, and mRNA-based therapeutics are intensifying demand for specialized purification kits and automated preparation instruments capable of handling complex biological matrices.

Regional Analysis:

• North America
  • United States
  • Canada
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa

North America, accounting for 30% of the share, enjoys the leading position in the market. North America's leadership in the global sample preparation market is underpinned by a convergence of structural advantages, including the world's largest concentration of pharmaceutical and biotechnology companies, a highly developed academic research infrastructure, and strong federal funding for life sciences and genomics programs. The region's advanced laboratory ecosystem supports widespread adoption of automated sample preparation platforms enabling high-throughput processing essential for clinical diagnostics, drug development, and environmental monitoring. Regulatory requirements from agencies including the U.S. FDA and Health Canada ensure standardized sample preparation procedures are deeply embedded in the workflows of both commercial and academic laboratories. The growing emphasis on personalized medicine, proteomics-based diagnostics, and liquid biopsy applications further drives innovation and investment in sample preparation technologies throughout the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES SAMPLE PREPARATION MARKET ANALYSIS

The United States represents the most significant individual country market for sample preparation globally, characterized by the highest concentration of pharmaceutical and biotechnology enterprises, research universities, and government-funded genomics and precision medicine programs. The robust clinical laboratory infrastructure across the country supports high-volume testing for cancer screening, infectious disease diagnosis, and genetic counseling, all fundamentally underpinned by advanced sample preparation workflows. Growing adoption of next-generation sequencing in both research and clinical settings is generating sustained demand for nucleic acid extraction kits, liquid handling systems, and automated extraction platforms capable of processing large sample batches. Federal initiatives supporting genomics-based healthcare, administered through agencies including the National Institutes of Health and the National Cancer Institute, continue to fund research programs that directly stimulate sample preparation technology adoption across academic medical centers and commercial laboratories. The FDA's mandate for validated sample preparation procedures in pharmaceutical testing, diagnostics, and food safety creates a consistent and structured demand environment. In 2025, 2,041,910 new cancer cases and 618,120 cancer deaths are expected to take place in the United States., reinforcing the country's leading role in precision oncology and molecular diagnostics and driving sustained sample preparation market growth across clinical and research settings.

EUROPE SAMPLE PREPARATION MARKET ANALYSIS

Europe represents the second-largest regional market for sample preparation, supported by a sophisticated network of research institutions, pharmaceutical manufacturers, and academic laboratories distributed across the continent. The European life sciences sector benefits from well-established regulatory frameworks administered by the European Medicines Agency, which mandate standardized sample preparation in drug development and quality control processes. Significant national and cross-border investment in genomics and proteomics research, along with expanding clinical diagnostics networks, reinforces demand for high-quality sample preparation instruments and consumables. Countries including Germany, the United Kingdom, France, and Switzerland host major pharmaceutical research hubs where advanced analytical workflows are integral to daily operations. The continent's growing focus on precision medicine and aging population-driven healthcare demands are expanding the need for molecular diagnostics and associated sample preparation technologies. According to the European Commission's Horizon Europe research program, health research received an allocation of approximately EUR 8.246 billion across the program's operational period, with significant funding directed toward genomics, oncology research, and molecular diagnostics that drive adoption of advanced sample preparation technologies across European laboratories.

ASIA-PACIFIC SAMPLE PREPARATION MARKET ANALYSIS

Asia-Pacific is among the fastest-growing regional markets for sample preparation, propelled by rapid expansion in pharmaceutical manufacturing, biotechnology research, and clinical diagnostics infrastructure. Countries such as China, India, Japan, South Korea, and Australia are investing heavily in life sciences R&D, with government-backed innovation programs fueling laboratory equipment procurement. The increasing burden of chronic diseases and infectious illnesses is amplifying demand for molecular diagnostic tools that rely on effective sample preparation workflows. The growth of contract research organizations and pharmaceutical contract manufacturing organizations in the region is further accelerating adoption of automated sample preparation platforms. Union Budget 2026-27 suggested the Biopharma SHAKTI with a budget of Rs. 10,000 crores across five years, focused on enhancing India's framework for the manufacture of biologics and biosimilars, creating a growing pipeline for laboratory sample preparation technologies across research and manufacturing facilities in the country.

LATIN AMERICA SAMPLE PREPARATION MARKET ANALYSIS

Latin America is an emerging market for sample preparation, driven by growing investments in healthcare infrastructure, pharmaceutical production, and academic research across key economies including Brazil and Mexico. The rising burden of infectious diseases and chronic conditions such as cancer and diabetes is creating increased demand for molecular diagnostics and the sample preparation workflows that support them. Government healthcare reforms aimed at expanding diagnostic testing capacity are reinforcing laboratory equipment adoption across the region. Academic institutions and public health laboratories are increasingly seeking automated and kit-based sample preparation solutions to improve testing efficiency and data quality.

MIDDLE EAST AND AFRICA SAMPLE PREPARATION MARKET ANALYSIS

The Middle East and Africa represent an emerging market for sample preparation, driven by expanding healthcare investments and the growing establishment of diagnostic laboratories across the region. Government-led healthcare modernization programs in Gulf Cooperation Council countries and South Africa are creating new demand for laboratory automation and molecular diagnostics platforms. The increasing prevalence of infectious diseases and non-communicable conditions, along with the expansion of pharmaceutical manufacturing in selected markets, are further creating avenues for sample preparation adoption. Rising investments in academic and clinical research infrastructure are opening new opportunities for instrument and consumable procurement across public and private healthcare sectors.

COMPETITIVE LANDSCAPE:

The global sample preparation market is characterized by intense competition among a diverse group of established life sciences companies, specialty laboratory suppliers, and emerging technology providers. Key players are focused on product innovation, strategic mergers and acquisitions, and the development of integrated automation platforms that combine instruments with proprietary reagents and consumables to create comprehensive end-to-end sample preparation solutions. Competition is shaped by the ability to deliver validated, regulatory-compliant workflows that meet the evolving demands of pharmaceutical, clinical, and environmental laboratories. Leading companies are also leveraging digital connectivity, artificial intelligence, and cloud-based monitoring to differentiate their instrument platforms and drive customer retention through ecosystem lock-in. Strategic investments in emerging markets, particularly within the Asia-Pacific and Latin American regions, are intensifying as established players seek to capture growing laboratory infrastructure demand. The increasing convergence of sample preparation with advanced sequencing and diagnostics platforms is reshaping competitive boundaries and creating opportunities for cross-segment innovation partnerships across the market.

The report provides a comprehensive analysis of the competitive landscape in the sample preparation market with detailed profiles of all major companies, including:

• Agilent Technologies Inc
• Bio-Rad Laboratories, Inc.
• Biotage
• F. Hoffmann-La Roche Ltd
• Hamilton Company
• Norgen Biotek Corp.
• PerkinElmer Inc.
• Phenomenex Inc. (Danaher Corporation)
• Qiagen N.V.
• Restek Corporation
• Tecan Trading AG
• Thermo Fisher Scientific Inc.
• Waters Corporation

KEY QUESTIONS ANSWERED IN THIS REPORT

1. How big is the sample preparation market?

2. What is the future outlook of the sample preparation market?

3. What are the key factors driving the sample preparation market?

4. Which region accounts for the largest sample preparation market share?

5. Which are the leading companies in the global sample preparation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Sample Preparation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Sample Preparation Instruments
  • 6.1.1 Market Trends
  • 6.1.2 Key Segments
    • 6.1.2.1 Extraction System
    • 6.1.2.2 Workstation
    • 6.1.2.3 Automated Evaporation System
    • 6.1.2.4 Liquid Handling Instrument
    • 6.1.2.5 Others
  • 6.1.3 Market Forecast
• 6.2 Consumables
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Sample Preparation Kit
  • 6.3.1 Market Trends
  • 6.3.2 Key Segments
    • 6.3.2.1 Purification Kit
    • 6.3.2.2 Isolation Kit
    • 6.3.2.3 Extraction Kit
  • 6.3.3 Market Forecast

7 Market Breakup by Application

• 7.1 Proteomics
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Genomics
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Epigenomics
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by End User

• 8.1 Pharmaceutical or Biotechnology Companies
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Food and Beverages Industry
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Research and Academic Institutes
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 SWOT Analysis

• 10.1 Overview
• 10.2 Strengths
• 10.3 Weaknesses
• 10.4 Opportunities
• 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 Agilent Technologies Inc
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
    • 14.3.1.3 Financials
    • 14.3.1.4 SWOT Analysis
  • 14.3.2 Bio-Rad Laboratories, Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Biotage
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 Financials
    • 14.3.3.4 SWOT Analysis
  • 14.3.4 F. Hoffmann-La Roche Ltd
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
  • 14.3.5 Hamilton Company
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
    • 14.3.5.4 SWOT Analysis
  • 14.3.6 Norgen Biotek Corp.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
  • 14.3.7 PerkinElmer Inc.
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Phenomenex Inc. (Danaher Corporation)
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
  • 14.3.9 Qiagen N.V.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
    • 14.3.9.3 Financials
    • 14.3.9.4 SWOT Analysis
  • 14.3.10 Restek Corporation
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio
  • 14.3.11 Tecan Trading AG
    • 14.3.11.1 Company Overview
    • 14.3.11.2 Product Portfolio
    • 14.3.11.3 Financials
    • 14.3.11.4 SWOT Analysis
  • 14.3.12 Thermo Fisher Scientific Inc.
    • 14.3.12.1 Company Overview
    • 14.3.12.2 Product Portfolio
    • 14.3.12.3 Financials
    • 14.3.12.4 SWOT Analysis
  • 14.3.13 Waters Corporation
    • 14.3.13.1 Company Overview
    • 14.3.13.2 Product Portfolio
    • 14.3.13.3 Financials
    • 14.3.13.4 SWOT Analysis